Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

KIT gene mutation and amplification in dysgerminoma of the ovary.

Cheng L, Roth LM, Zhang S, Wang M, Morton MJ, Zheng W, Abdul Karim FW, Montironi R, Lopez-Beltran A.

Cancer. 2011 May 15;117(10):2096-103. doi: 10.1002/cncr.25794. Epub 2010 Nov 30.

2.

Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.

Hersmus R, Stoop H, van de Geijn GJ, Eini R, Biermann K, Oosterhuis JW, Dhooge C, Schneider DT, Meijssen IC, Dinjens WN, Dubbink HJ, Drop SL, Looijenga LH.

PLoS One. 2012;7(8):e43952. doi: 10.1371/journal.pone.0043952. Epub 2012 Aug 28.

3.

c-KIT codon 816 mutation in a recurrent and metastatic dysgerminoma of a 14-year-old girl: case study.

Pauls K, Wardelmann E, Merkelbach-Bruse S, Büttner R, Zhou H.

Virchows Arch. 2004 Dec;445(6):651-4. Epub 2004 Sep 29.

PMID:
15455230
4.

Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications.

Sever M, Jones TD, Roth LM, Karim FW, Zheng W, Michael H, Hattab EM, Emerson RE, Baldridge LA, Cheng L.

Mod Pathol. 2005 Nov;18(11):1411-6.

5.

Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.

Hoei-Hansen CE, Kraggerud SM, Abeler VM, Kaern J, Rajpert-De Meyts E, Lothe RA.

Mol Cancer. 2007 Feb 2;6:12.

6.

Chromosome 12p abnormalities in dysgerminoma of the ovary: a FISH analysis.

Cossu-Rocca P, Zhang S, Roth LM, Eble JN, Zheng W, Karim FW, Michael H, Emerson RE, Jones TD, Hattab EM, Cheng L.

Mod Pathol. 2006 Apr;19(4):611-5.

7.

Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation.

Werness BA, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, Tsukada Y, Ponder BA, Piver MS.

Int J Gynecol Pathol. 2000 Oct;19(4):390-4.

PMID:
11109172
8.

Cytokeratin and CD30 expression in dysgerminoma.

Cossu-Rocca P, Jones TD, Roth LM, Eble JN, Zheng W, Karim FW, Cheng L.

Hum Pathol. 2006 Aug;37(8):1015-21. Epub 2006 May 26.

PMID:
16867864
9.

Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.

Kersemaekers AM, Honecker F, Stoop H, Cools M, Molier M, Wolffenbuttel K, Bokemeyer C, Li Y, Lau YF, Oosterhuis JW, Looijenga LH.

Hum Pathol. 2005 May;36(5):512-21.

PMID:
15948118
10.

OCT4: a novel biomarker for dysgerminoma of the ovary.

Cheng L, Thomas A, Roth LM, Zheng W, Michael H, Karim FW.

Am J Surg Pathol. 2004 Oct;28(10):1341-6.

PMID:
15371950
11.

Aggressive systemic mastocytosis after germ cell tumor of the ovary: C-KIT mutation documentation in both disease states.

Lee JW, Yang WS, Chung SY, Kang JH, Cho B, Kim HK, Kim KM, Jeong DC.

J Pediatr Hematol Oncol. 2007 Jun;29(6):412-5.

PMID:
17551405
12.

KIT mutations are common in testicular seminomas.

Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D, Cummings OW, Wait C, Town A, Heinrich MC.

Am J Pathol. 2004 Jan;164(1):305-13.

13.

c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.

Biermann K, Göke F, Nettersheim D, Eckert D, Zhou H, Kahl P, Gashaw I, Schorle H, Büttner R.

J Pathol. 2007 Nov;213(3):311-8.

PMID:
17768701
14.

Occurrence of seminoma and dysgerminoma in father and daughter.

Yule SM, Dawes PJ, Malcolm AJ, Pearson AD.

Pediatr Hematol Oncol. 1994 Mar-Apr;11(2):211-3.

PMID:
8204448
15.

[Expression and mutation of c-kit gene in gastrointestinal stromal tumor].

Ma D, Liu X, Cai Z, Xie Q.

Zhonghua Zhong Liu Za Zhi. 2002 Sep;24(5):461-4. Chinese.

PMID:
12485499
16.

Mos oncogene expression in human ovarian tumors.

Xerri L, Charpin C, Hassoun J, Birnbaum D, Delapeyriere O.

Anticancer Res. 1991 Jul-Aug;11(4):1629-34.

PMID:
1836123
17.

N822K c-kit mutation in CD30-positive cutaneous pleomorphic mastocytosis after germ cell tumour of the ovary.

Baek JO, Kang HK, Na SY, Lee JR, Roh JY, Lee JH, Kim HJ, Park S.

Br J Dermatol. 2012 Jun;166(6):1370-3. doi: 10.1111/j.1365-2133.2012.10816.x. Epub 2012 Mar 14. No abstract available.

PMID:
22233328
18.

Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults.

McIntyre A, Summersgill B, Grygalewicz B, Gillis AJ, Stoop J, van Gurp RJ, Dennis N, Fisher C, Huddart R, Cooper C, Clark J, Oosterhuis JW, Looijenga LH, Shipley J.

Cancer Res. 2005 Sep 15;65(18):8085-9.

19.

The impact of c-kit and ki-67 expression on patients prognosis in advanced ovarian serous carcinoma.

Khalifeh I, Munkarah AR, Schimp V, Morris R, Lawrence WD, Ali-Fehmi R.

Int J Gynecol Pathol. 2005 Jul;24(3):228-34.

PMID:
15968197
20.

XY female with a dysgerminoma and no mutation in the coding sequence of the SRY gene.

Morerio C, Calvari V, Rosanda C, Porta S, Gambini C, Panarello C.

Cancer Genet Cytogenet. 2002 Jul 1;136(1):58-61.

PMID:
12165453

Supplemental Content

Support Center